BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8084589)

  • 1. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX.
    Natoli G; Avantaggiati ML; Chirillo P; Puri PL; Ianni A; Balsano C; Levrero M
    Oncogene; 1994 Oct; 9(10):2837-43. PubMed ID: 8084589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX.
    Natoli G; Avantaggiati ML; Chirillo P; De Marzio E; Collepardo D; Falco M; Balsano C; Levrero M
    J Hepatol; 1995; 22(1 Suppl):14-20. PubMed ID: 7602067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
    Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.
    Binétruy B; Smeal T; Karin M
    Nature; 1991 May; 351(6322):122-7. PubMed ID: 1903181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation.
    Büscher D; Dello Sbarba P; Hipskind RA; Rapp UR; Stanley ER; Baccarini M
    Oncogene; 1993 Dec; 8(12):3323-32. PubMed ID: 8247534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements.
    Avantaggiati ML; Natoli G; Balsano C; Chirillo P; Artini M; De Marzio E; Collepardo D; Levrero M
    Oncogene; 1993 Jun; 8(6):1567-74. PubMed ID: 8502480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
    Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
    Cosgaya JM; Aranda A
    Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
    Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.
    Natoli G; Avantaggiati ML; Chirillo P; Costanzo A; Artini M; Balsano C; Levrero M
    Mol Cell Biol; 1994 Feb; 14(2):989-98. PubMed ID: 7507209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor.
    Baichwal VR; Park A; Tjian R
    Nature; 1991 Jul; 352(6331):165-8. PubMed ID: 1906140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway.
    Nilsson M; Ford J; Bohm S; Toftgård R
    Cell Growth Differ; 1997 Aug; 8(8):913-20. PubMed ID: 9269900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.